Artigo Revisado por pares

HEALTH ISSUES OF MEN: PREVALENCE AND CORRELATES OF ERECTILE DYSFUNCTION

2005; Lippincott Williams & Wilkins; Volume: 174; Issue: 2 Linguagem: Inglês

10.1097/01.ju.0000165389.73148.d1

ISSN

1527-3792

Autores

Ridwan Shabsigh, Michael A. Perelman, Daniel C. Lockhart, Tom F. Lue, Gregory A. Broderick,

Tópico(s)

Urinary Bladder and Prostate Research

Resumo

No AccessJournal of UrologyAdult Urology: Outcomes/Epidemiology/Socioeconomics1 Aug 2005HEALTH ISSUES OF MEN: PREVALENCE AND CORRELATES OF ERECTILE DYSFUNCTION R. SHABSIGH, M.A. PERELMAN, D.C. LOCKHART, T.F. LUE, and G.A. BRODERICK R. SHABSIGHR. SHABSIGH , M.A. PERELMANM.A. PERELMAN , D.C. LOCKHARTD.C. LOCKHART , T.F. LUET.F. LUE , and G.A. BRODERICKG.A. BRODERICK View All Author Informationhttps://doi.org/10.1097/01.ju.0000165389.73148.d1AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract Purpose: The Cross-National Survey on Men's Health Issues was a population based, international survey of men using the health care systems of participating countries. The prevalence of erectile dysfunction (ED) and its correlation with patient age, overall health and comorbidities were assessed. Materials and Methods: Men who were 20 to 75 years old in the United States, Germany, United Kingdom, France, Italy and Spain were recruited to participate in the study. During visits to physician offices participants completed a screening questionnaire about their overall health, and problems with prostate, urination and penile erection. Men who reported ED completed a followup questionnaire. Results: A cohort of 28,691 men completed the screening questionnaire and provided their age. Respondents in the oldest age group (70 to 75 years) were at 14-fold higher relative risk for ED than respondents in the youngest age group (20 to 29 years). ED correlated positively with poor overall health, and prostate and urinary problems. The prevalence of comorbid conditions increased with ED severity. Only a small percent of men with ED (2% to 8%) were using nitrates for comorbid cardiac disorders. Approximately 10% to 20% of men were on β-blockers. Conclusions: The results of this survey are consistent with those of other population based reports showing a high correlation between ED prevalence and patient age, and ED and lower urinary tract symptoms. The prevalence of comorbidities, such as vascular conditions, increased with ED severity, which may indicate that ED is a prognostic marker of overall health and an important medical condition. References 1 NIH Consensus Conference: Impotence. NIH Consensus Development Panel on Impotence. JAMA1993; 270: 83. Google Scholar 2 Impotence. NIH Consensus Statement1992; 10: 1. Available at http://consensus.nih.gov/cons/091/091_statement.pdf. Accessed May 15, 2004. Google Scholar 3 : Prevalence of erectile dysfunction: a systematic review of population-based studies. Int J Impot Res2002; 14: 422. Google Scholar 4 : Epidemiology of erectile dysfunction. Int J Impot Res2003; 15: 63. Google Scholar 5 : Erectile dysfunction: prevalence, etiology, and major risk factors. J Am Osteopath Assoc2002; 102: S1. Google Scholar 6 : Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol1994; 151: 54. Link, Google Scholar 7 : The prevalence of hypertension, hyperlipidemia, diabetes mellitus and depression in men with erectile dysfunction. J Urol2004; 171: 2341. Link, Google Scholar 8 : Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial. JAMA2004; 291: 2978. Google Scholar 9 : Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7). Eur Urol2003; 44: 637. Google Scholar 10 : Sexual dysfunction in men with lower urinary tract symptoms and benign prostatic hyperplasia: an emerging link. BJU Int2003; 92: 822. Google Scholar 11 : Lower urinary tract symptoms and erectile dysfunction: co-morbidity or typical "Aging Male" symptoms? Results of the "Cologne Male Survey.". Eur Urol2003; 44: 588. Google Scholar 12 : Drivers and barriers to seeking treatment for erectile dysfunction: a comparison of six countries. BJU Int2004; 94: 1055. Google Scholar 13 Shabsigh, R., Perelman, M. A. and Lockhart, D. C.: Treatment-seeking behavior in men with erectile dysfunction in six countries: motivators and barriers. Presented at 10th World Congress of the International Society for Sexual and Impotence Research, Montreal, Canada, September 22–26, 2002 Google Scholar 14 : The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology1997; 49: 822. Crossref, Medline, Google Scholar 15 : Epidemiology of erectile dysfunction: results of the 'Cologne Male Survey.'. Int J Impot Res2000; 12: 305. Google Scholar 16 : Erectile dysfunction in general medicine practice: prevalence and clinical correlates. Int J Impot Res2000; 12: 41. Google Scholar 17 : Epidemiology of erectile dysfunction in four countries: cross-national study of the prevalence and correlates of erectile dysfunction. Urology2003; 61: 201. Google Scholar 18 Perelman, M. A., Shabsigh, R., Seftel, A. D., Althof, S. A. and Lockhart, D. C.: Attitudes of men with erectile dysfunction: a cross-national survey. Unpublished data Google Scholar 19 : Introduction: erectile dysfunction and cardiovascular risk factors. Am J Cardiol2003; 92: 1. Google Scholar 20 : Clinical evaluation and management strategy for sexual dysfunction in men and women. J Sex Med2004; 1: 49. Google Scholar Department of Urology, Columbia University (RS) and Department of Psychiatry, Reproductive Medicine and Urology, New York Weill Cornell Medical Center (MAP), New York, New York, Eli Lilly and Co. (DCL), Indianapolis, Indiana, Department of Urology, University of California-San Francisco (TFL), San Francisco, California, and Department of Urology, Mayo Clinic College of Medicine (GAB), Jacksonville, Florida© 2005 by American Urological Association, Inc.FiguresReferencesRelatedDetailsCited byMagri V, Wagenlehner F, Perletti G, Schneider S, Marras E, Naber K and Weidner W (2010) Use of the UPOINT Chronic Prostatitis/Chronic Pelvic Pain Syndrome Classification in European Patient Cohorts: Sexual Function Domain Improves CorrelationsJournal of Urology, VOL. 184, NO. 6, (2339-2345), Online publication date: 1-Dec-2010.Castagnetti M, Tocco A, Capizzi A, Rigamonti W and Artibani W (2010) Sexual Function in Men Born With Classic Bladder Exstrophy: A Norm Related StudyJournal of Urology, VOL. 183, NO. 3, (1118-1122), Online publication date: 1-Mar-2010.Tong Y, Tar M, Monrose V, DiSanto M, Melman A and Davies K (2007) hSMR3A as a Marker for Patients With Erectile DysfunctionJournal of Urology, VOL. 178, NO. 1, (338-343), Online publication date: 1-Jul-2007.Travison T, Shabsigh R, Araujo A, Kupelian V, O'Donnell A and McKinlay J (2018) The Natural Progression and Remission of Erectile Dysfunction: Results From the Massachusetts Male Aging StudyJournal of Urology, VOL. 177, NO. 1, (241-246), Online publication date: 1-Jan-2007. Volume 174Issue 2August 2005Page: 662-667 Advertisement Copyright & Permissions© 2005 by American Urological Association, Inc.Keywordsquestionnairescomorbidityimpotenceage distributionpenisMetricsAuthor Information R. SHABSIGH More articles by this author M.A. PERELMAN More articles by this author D.C. LOCKHART More articles by this author T.F. LUE More articles by this author G.A. BRODERICK More articles by this author Expand All Advertisement PDF downloadLoading ...

Referência(s)
Altmetric
PlumX